Table 5.
Lung function parameter | I measurement (beginning of the PTB treatment) | II measurement (2 months of the PTB treatment) | III measurement (6 months of the PTB treatment) | Significance* | Differences between measurements*
|
||
---|---|---|---|---|---|---|---|
I vs II | II vs III | I vs III | |||||
FVC (%) | 71.36±13.62 | 74.25±19.14 | 77.39±15.36 | I vs III: P<0.01 | −2.88±15.48 | −3.14±12.44 | −6.02±13.96 |
FEV1 (%) | 73.54±16.33 | 72.77±17.85 | 71.99±20.08 | No significance | 0.77±10.22 | 0.78±8.23 | 1.55±12.17 |
FEV1/FVC ×100% | 80.93±8.59 | 76.16±7.51 | 74.46±10.47 | I vs II: P<0.001; I vs III: P<0.001 | 4.76±6.75 | 1.70±7.48 | 6.46±9.00 |
TLC (%) | 79.5±10.10 | – | 80.30±15.91 | No significance | – | – | −0.80±13.05 |
Notes: FEV1/FVC ×100%, percentage ratio of FEV1/FVC. Data presented as mean ± standard deviation.
One-way ANOVA and Tukey’s post hoc test.
Abbreviations: ANOVA, analysis of variance; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; PTB, pulmonary tuberculosis; TLC, total lung capacity; –, no measurement made.